Pharma poised to up US online ad spend, says eMarketer

Share this article:
Healthcare and pharma advertisers' US online ad spend is expected to see double-digit growth over the next few years, rising from $1.03 billion in 2010 to $1.86 billion in 2015, eMarketer predicts.
The industry accounted for 4.0% of the $25.8 billion spent on overall US online advertising last year, according to new estimates from eMarketer, and its share is set to climb to 4.2% by 2015. For this year, the firm forecasted, the industry will up web spend 13% to $1.17 billion, not including online journal ads.
On a percentage growth basis, that puts the health and pharma vertical roughly on par with the retail and automotive industries, pegged to see 11% and 14% growth this year, respectively, and behind consumer packaged goods, which is forecast to grow internet spend 29% to $2.7 billion. Looking ahead, retailers will soon account for more than one in every five online ad dollars, noted eMarketer.
These other industries are increasing use of online video ads as an alternative to pricy TV commercials, according to the intelligence firm. Drug manufacturers and marketers, seeing brand revenues shrink from expiries, are also investing more heavily in web promotion this year, as they try to make the most of big brands due to go off patent, said Victoria Petrock, eMarketer senior research analyst.
“Healthcare and pharma spending will continue to move online, but spending will likely be affected by the loss of patent protection for several blockbuster drugs and forthcoming guidelines from the US Food & Drug Administration, which many in the industry hope will provide clearer direction for how pharmaceutical products can be marketed online,” eMarketer said in a statement.
Petrock said the lack of blockbusters in the pipeline “could potentially decrease spend over time.”
Doctors, hospitals and other entities that deliver health services, such as HMOs, are expected to contribute to the upward trend. More mature online advertising verticals—including telecom, financial services and travel—are expected to grow online spend but lose share through 2015 because they are already heavily invested online, eMarketer said.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?